THRX

Theravance, Inc. News Headlines

$15.03
*  
0.48
3.3%
Get THRX Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Are You Betting Too Much On Theravance?
11/1/2013 11:28:00 AM - Seeking Alpha


Loss at Theravance Narrower Than Expected - Analyst Blog
10/25/2013 1:06:58 PM - Zacks.com


Novartis - Make Money From COPD Opportunity
10/7/2013 1:59:00 PM - Seeking Alpha


Japanese Approval for Theravance/Glaxo Drug - Analyst Blog
9/23/2013 10:39:20 AM - Zacks.com


Novartis' Ultibro Breezhaler Approved in Europe - Analyst Blog
9/23/2013 10:39:13 AM - Zacks.com


CHMP Positive on GSK/THRX candidate - Analyst Blog
9/20/2013 10:30:01 AM - Zacks.com


Sector Update: Healthcare Shares Mixed Pre-Market; Sarepta Sinks 10% on GlaxoSmithKline, Prosensa Study
9/20/2013 7:22:09 AM - MT Newswires


Sector Update: Healthcare
9/20/2013 7:17:31 AM - MT Newswires


FDA Panel Backs THRX/GSK Candidate - Analyst Blog
9/11/2013 5:58:03 PM - Zacks.com


Sector Update: Healthcare
9/11/2013 2:48:23 PM - MT Newswires


Healthcare Stocks Still Higher Near Bell; Theravance Rallies After FDA Advisory Panel Recommends New COPD Drug
9/11/2013 2:46:34 PM - MT Newswires


Encouraging News from THRX's TD-4208 - Analyst Blog
9/5/2013 10:50:01 AM - Zacks.com


Theravance Is Splitting Into Two Very Appealing Companies With Medium-Term Upside Of At Least 50%
8/30/2013 9:58:00 AM - Seeking Alpha


Good News for Theravance - Analyst Blog
8/15/2013 4:15:01 PM - Zacks.com


Seth Klarman's Top 5 Second Quarter Holdings
8/14/2013 5:30:38 PM - GuruFocus


Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update
8/14/2013 12:57:00 PM - Seeking Alpha


FDA Panel to Review THRX/GSK Candidate - Analyst Blog
8/9/2013 1:15:01 PM - Zacks.com


Theravance Narrows Loss - Analyst Blog
7/26/2013 3:58:28 PM - Zacks.com


Theravance's Vibativ Expanded in the US - Analyst Blog
6/24/2013 4:32:10 PM - Zacks.com


Elan Explores Sale Options - Analyst Blog
6/17/2013 3:30:29 PM - Zacks.com


Elan Shareholders Bring Management To Heel
6/17/2013 1:40:00 PM - Investopedia


AstraZeneca Pays Up To Patch Up Another Key Area
6/10/2013 12:55:00 PM - Investopedia


Elan Rejects Royalty Offer Again - Analyst Blog
5/24/2013 3:28:15 PM - Zacks.com


Elan Provides Strategic Update - Analyst Blog
5/21/2013 3:27:15 PM - Zacks.com


The Billion Dollar COPD Deal: Who Gains The Most?
5/17/2013 11:27:00 AM - Seeking Alpha